Search

everythinglearnresearchcommunity

for

Search:↓

People with palmoplantar pustulosis, especially with bone issues, have different mouth bacteria compared to healthy people.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Children with frequent respiratory infections may have low levels of zinc, iron, and copper.

Oral testosterone therapy raises heart risk more than other methods.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.

Defective protein folding due to a mutation is key in ANE syndrome.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Scalp cooling significantly reduces chemotherapy-induced hair loss.

Some birth control pills have a higher risk of blood clots than others.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Topical minoxidil significantly increases hair growth in androgenetic alopecia but only some patients see cosmetically acceptable results.

An 80-year-old man's deep beard infection was cured with oral terbinafine after identifying the fungus Trichophyton verrucosum.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

Women with irregular periods have a higher risk of heart disease.